Reliance Pharma Fund (G)

Reliance Pharma Fund (G)

Summary Info
Fund Name : Reliance Mutual Fund
Scheme Name : Reliance Pharma Fund (G)
AMC : Reliance Mutual Fund
Type : Open
Category : Equity - Pharma
Launch Date : 10-May-04
Fund Manager : Sailesh Raj Bhan
Net Assets (Rs. cr) : 817.09

NAV Details

NAV Date : 17-Apr-14
NAV [Rs.] : 87.9
Buy/Resale Price [Rs.] : 87.00
Sell/Repurchase Price [Rs.] : 87.88
Entry Load % : Nil
Exit Load % : NIL

NAV Chart

Graph: 1m |   3m |   6m |   1y |   3y


* returns above 1 yr. are annualized

  1w 1m 3m 6m 1y 3y 5y Since INC
Scheme Returns [0.1] 2.2 4.6 18.8 29.3 16.2 33.9 24.6
Category Avg 0.2 1.8 4.1 15.0 29.2 17.4 31.8 20.7
Category Best 0.6 2.3 4.8 19.2 30.6 22.0 33.9 26.1
Category Worst [0.1] 0.8 2.8 11.4 27.2 15.3 26.2 11.9

Latest Payouts

  Dividends Bonus
Ratio NA NA
Date NA NA

Investment Details

Tax Benefits : 112(1) 
Min. Investment(Rs.) : 5,000.00
Increm.Investment(Rs.) : 1.00

In & Out

Name of the Company No of shares
No fresh investments made in
Name of the Company No of shares
Ranbaxy Labs. 150,500
Unichem Labs. 176,612

Fund Holdings

As on 30-Jun-2013

Asset TypeInstrument NameIndustryNet Assets
No of SharesMkt Value
Equity & Equity related Investments
Equitydivi's laboratories ltdPharmaceuticals10.1700,00069.4
Equitysun pharmaceuticals industries ltdPharmaceuticals8.5575,00058.2
Equitysanofi india ltdPharmaceuticals8.4235,81057.3
Equityranbaxy laboratories ltdPharmaceuticals8.11,800,70055.7
Equitydr. reddy's laboratories ltdPharmaceuticals8.1250,10055.5
Equitycipla ltdPharmaceuticals8.01,397,30354.8
Equityglaxosmithkline pharmaceuticals ltdPharmaceuticals6.7197,90046.2
Equityindoco remedies ltdPharmaceuticals5.45,831,33837.3
Equityzydus wellness ltdFMCG5.2560,64535.8
Equityabbott india ltdPharmaceuticals5.1241,00035.2
Equitylupin ltdPharmaceuticals4.8425,00033.2
Equitysun pharma advanced research company ltdMiscellaneous4.32,132,50529.4
Equityipca laboratories ltdPharmaceuticals4.3450,00029.5
Equitycadila healthcare ltdPharmaceuticals3.4300,35123.3
Equitybiocon ltdPharmaceuticals3.3800,00022.5
Equityglenmark pharmaceuticals ltdPharmaceuticals2.8350,00019.2
Equityfulford india ltdPharmaceuticals1.1124,4017.4
Equitymerck ltdPharmaceuticals0.996,8266.3
Equityunichem laboratories ltdPharmaceuticals0.7289,5744.8
Equityvimta labs ltdMiscellaneous0.1310,3130.7
Debt Investments
NCDdr. reddy's laboratories ltdAA+0.0318,6000.2
Cash & Cash Equivalent
Reverse Reporeverse repoUR / N.A.0.5NA3.1
Net CA & Othersnet current assets-/-0.2NA1.5
CBLOcbloUR / N.A.0.0NA0.3

My Watchlist

Key Information

Fund House: Reliance Mutual Fund
Incorporation Date : 24-Feb-1995
Total Assets Managed (Cr.) : 26,420.11
Trustee/s : S Santhanakrishnan
Chairman : N/A
CEO / MD : Mr. Sundeep Sikka
President : N/A
Director/s : Sushil C. Tripathi
Compliance Officer/s : Mr. Muneesh Sud
Investor Service Officer/s : Mr. Bhalchandra Joshi
Fund Manager/s : Sailesh Raj Bhan

Other Information

Auditors :  N/A
Registered Office : One Indiabulls Centre, Tower 1, ,12th Flr, 841, Senapati Bapat ,Marg, Elphinstone Road, Mumbai-400013
Contact Nos : 022-30994600
Fax : 022-30994699
Email :
Website :

Fund Manager Speak

V Balasubramanian, Head-Equity & Fund Manager – Equity & Gold, IDBI Asset Management Ltd
“The policy tightening measures by the RBI to ease inflation is not anticipated at this moment, while at the same time a reduction in key policy rates is a..
Jimmy Patel, CEO, Quantum Asset Management
Kaushik Dani, Head – Equity Funds, Peerless Mutual Fund
View all Fund Manager Speak >>

IIFL Blogs

R. Venkataraman
Based on my limited readings on Islam, I found it a very practical religion. “If the mountain does not come to Mohammed, then Mohammed must go to the mountain” – is a statement attributed to The Pr...
Anu Jain
Hungry kya??? The American markets closed more than 3% down on fresh European panic, this time from Hungary and poor American domestic non-farm payroll data. Just when one thought that maybe after...